Xinhua Pharmaceutical announced that Shandong Zibo Xinda Pharmaceutical Co., Ltd., a wholly-owned subsidiary, recently received a registration certificate for donepezil hydrochloride tablets approved and issued by the State Drug Administration. The specification is 5 mg. The registration classification is Class 4 chemicals, and the drug approval number is Sinopharm Standard H20266009. The drug was approved for registration in September 2026 for the treatment of mild, moderate or severe symptoms of Alzheimer's disease.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.